Clinical effectiveness and cost-effectiveness of elemental nutrition for the maintenance of remission in Crohn’s disease: a systematic review and meta-analysis

Health Technology Assessment - Tập 19 Số 26 - Trang 1-138
Alexander Tsertsvadze1, Tara Gurung1, Rachel Court1, Aileen Clarke1, Paul Sutcliffe1
1Warwick Evidence, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK

Tóm tắt

BackgroundAlthough enteral nutrition has been shown to be a viable treatment option for the management of active Crohn’s disease (CD), the evidence regarding its clinical benefits compared with standard treatments (e.g. steroids) for maintaining remission in patients with CD has been inconsistent. If enteral nutrition was to be effective, the use of drugs such as steroids and immunosuppressive drugs could be reduced, thereby reducing the likelihood of adverse events associated with these medications.ObjectivesThis systematic review aimed to assess the clinical effectiveness and cost-effectiveness of elemental nutrition (a type of enteral nutrition) for maintenance of remission in patients with CD.Data sourcesMajor bibliographic databases (e.g. MEDLINE, EMBASE, Cochrane Database of Systematic Reviews) were searched from inception to August/September 2013. Searches were not limited by study design, language or publication date. Websites for relevant organisations and references of included studies were checked.MethodsExperimental randomised and non-randomised controlled trials (RCTs and nRCTs) reporting clinical effectiveness and cost-effectiveness of elemental nutrition in the maintenance of remission in patients with CD were eligible. Study selection, data extraction and risk of bias (RoB) assessment were performed independently. Risk ratios (RRs) and mean differences (MDs) were pooled using a random-effects model. Heterogeneity was assessed via forest plots, Cochran’sQand theI2statistics. Overall, quality of evidence for each outcome was rated using the Grading of Recommendations, Assessment, Development, and Evaluation approach.ResultsEight studies (three RCTs and five nRCTs) were included in the review. RCTs indicated a significant benefit of elemental nutrition vs. no intervention (an unrestricted diet) in maintaining remission at 24 months [one RCT; RR 2.06, 95% confidence interval (CI) 1.00 to 4.43; very low-grade evidence] and preventing relapse at 12–24 months post baseline (two RCTs; pooled RR 0.57, 95% CI 0.38 to 0.84;I2 = 0%; high-grade evidence). Similarly, three nRCTs showed significant benefits of elemental nutrition over no intervention in maintaining remission at 12–48 months and preventing relapse at 12 months post baseline (MD 1.20 months, 95% CI 0.35 to 2.04 months). The incidence of mucosal healing was not significantly different in the intervention and control groups (RR 2.70, 95% CI 0.62 to 11.72). Adherence to an elemental nutrition regime was significantly worse than adherence to polymeric nutrition (RR 0.68, 95% CI 0.50 to 0.92) and, when compared with other active treatments (medications, polymeric nutrition or a combination), elemental nutrition yielded non-significant results with wide 95% CIs, rendering these results inconclusive. Complications and adverse events were too sparse to allow meaningful comparisons. None of the studies reported cost-effectiveness of elemental nutrition. Owing to scarcity of data, subgroup and sensitivity analyses could not be performed to explore methodological and clinical sources of heterogeneity.LimitationsThe findings warrant cautious interpretation given the limitations of the evidence in methodological quality (small samples, short follow-up) and the RoB in individual studies (lack of blinding, confounding).ConclusionsLimited evidence indicates potential benefits of elemental nutrition against no intervention in the maintenance of remission and prevention of relapse in adult patients with CD. There was a lack or insufficient evidence on adverse events and complications. Future large and long-term randomised trials are warranted to draw more definitive conclusions regarding the effects of elemental nutrition in maintaining remission in CD.Trial registrationThis study is registered as PROSPERO CRD42013005134.FundingThe National Institute for Health Research Health Technology Assessment programme.

Từ khóa


Tài liệu tham khảo

Donnellan, 2013, Nutritional management of Crohn’s disease, Ther Adv Gastroenterol, 6, 231, 10.1177/1756283X13477715

American College of Gastroenterology. Advancing Gastroenterology Ipc. Inflammatory Bowel Disease. URL: http://patients.gi.org (accessed 28 October 2013).

Sandhu, 2010, Guidelines for the management of inflammatory bowel disease in children in the United Kingdom, J Pediatr Gastroenterol Nutr, 50, S1, 10.1097/MPG.0b013e3181c92c53

Sartor, 2006, Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis, Nat Clin Pract Gastroenterol Hepatol, 3, 390, 10.1038/ncpgasthep0528

, 2007, Living With Crohn’s Disease The Real Impact

Akobeng, 2008, Crohn’s disease: current treatment options, Arch Dis Child, 93, 787, 10.1136/adc.2007.128751

National Institute for Health and Clinical Excellence (NICE). NICE Clinical Guideline 152: Crohn’s Disease: Management in Adults, Children and Young People (CG152) 2012. URL: www.nice.org.uk/CG152 (accessed 24 October 2013).

Lichtenstein, 2009, Management of Crohn’s disease in adults, Am J Gastroenterol, 104, 465, 10.1038/ajg.2008

Bernstein CN, Fried M, Krabshuis JH. World Gastroenterology Organisation (WGO) Global Guidelines. Inflammatory Bowel Disease: A Global Perspective. 2009. URL: www.worldgastroenterology.org (accessed 25 October 2013).

BUPA. Crohn’s Disease. URL: www.bupa.co.uk/health-information/directory/c/crohns-disease (accessed 25 October 2013).

Binder, 1985, Prognosis in Crohn’s disease – based on results from a regional patient group from the county of Copenhagen, Gut, 26, 146, 10.1136/gut.26.2.146

Cohen, 2002, The quality of life in patients with Crohn’s disease, Aliment Pharmacol Ther, 16, 1603, 10.1046/j.1365-2036.2002.01323.x

Canavan, 2006, Long-term prognosis in Crohn’s disease: factors that affect quality of life, Aliment Pharmacol Ther, 23, 377, 10.1111/j.1365-2036.2006.02753.x

Canavan, 2007, Long-term prognosis in Crohn’s disease: an epidemiological study of patients diagnosed more than 20 years ago in Cardiff, Aliment Pharmacol Ther, 25, 59, 10.1111/j.1365-2036.2006.03132.x

Talley, 2011, An evidence-based systematic review on medical therapies for inflammatory bowel disease, Am J Gastroenterol, 106, S2, 10.1038/ajg.2011.58

Hovde, 2012, Epidemiology and clinical course of Crohn’s disease: results from observational studies, World J Gastroenterol, 18, 1723, 10.3748/wjg.v18.i15.1723

Mayberry, 2013, NICE clinical guideline (CG152): the management of Crohn’s disease in adults, children and young people, Aliment Pharmacol Ther, 37, 195, 10.1111/apt.12102

Sica, 2013, Surgery for inflammatory bowel disease in the era of laparoscopy, World J Gastroenterol, 19, 2445, 10.3748/wjg.v19.i16.2445

Lloyd, 2002, Crohn’s Disease and Ulcerative Colitis: Divergent Trends in Hospital Admission Rates 1989/90 to 1999/2000, Health Stat Q

Lichtenstein, 2010, Emerging prognostic markers to determine Crohn’s disease natural history and improve management strategies: a review of recent literature, Gastroenterol Hepatol, 6, 99

Bassi, 2004, Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study, Gut, 53, 1471, 10.1136/gut.2004.041616

Freeman, 2008, Use of the Crohn’s disease activity index in clinical trials of biological agents, World J Gastroenterol, 14, 4127, 10.3748/wjg.14.4127

Baumgart, 2012, Crohn’s disease, Lancet, 380, 1590, 10.1016/S0140-6736(12)60026-9

Hanauer, 2001, Management of Crohn’s disease in adults, Am J Gastroenterol, 96, 635, 10.1111/j.1572-0241.2001.03671.x

Zachos, 2007, Enteral nutritional therapy for induction of remission in Crohn’s disease, Cochrane Database Syst Rev, 1, CD000542

Makola, 2005, Elemental and semi-elemental formulas: are they superior to polymeric formulas?, Pract Gastroenterol, 14, 59

Chen, 2001, Enteral nutrition and acute pancreatitis, World J Gastroenterol, 7, 185, 10.3748/wjg.v7.i2.185

Yamamoto, 2007, Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn’s disease: a prospective, non-randomised, parallel, controlled study, Aliment Pharmacol Ther, 25, 67, 10.1111/j.1365-2036.2006.03158.x

Day, 2009, Exclusive enteral nutrition: a nutritional approach to Crohn’s disease, Pract Gastroenterol, 33, 34

Akobeng, 2009, Enteral nutrition for maintenance of remission in Crohn’s disease, Cochrane Database Syst Rev, 3, CD005984

Alhagamhmad, 2012, An update of the role of nutritional therapy in the management of Crohn’s disease, J Gastroenterol, 47, 872, 10.1007/s00535-012-0617-9

Critch, 2012, Use of enteral nutrition for the control of intestinal inflammation in paediatric Crohn disease, J Paediatr Gastroenterol Nutr, 54, 298, 10.1097/MPG.0b013e318235b397

Wilschanski, 1996, Supplementary enteral nutrition maintains remission in paediatric Crohn’s disease, Gut, 38, 543, 10.1136/gut.38.4.543

Heuschkel, 2000, Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children, J Paediatr Gastroenterol Nutr, 31, 8, 10.1097/00005176-200007000-00005

Yamamoto, 2010, Enteral nutrition for the maintenance of remission in Crohn’s disease: a systematic review, Eur J Gastroenterol Hepatol, 22, 1, 10.1097/MEG.0b013e32832c788c

Lochs, 2006, ESPEN guidelines on enteral nutrition: gastroenterology, Clin Nutr, 25, 260, 10.1016/j.clnu.2006.01.007

Sutcliffe P, Tsertsvadze A, Court R, Pulikottil-Jacob R, Kandala N-B, Gurung T, et al. Elemental nutrition for Crohn’s disease. PROSPERO 2013:CRD42013005134. URL: www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42013005134 (accessed 25 October 2013).

Rajendran, 2010, Role of diet in the management of inflammatory bowel disease, World J Gastroenterol, 16, 1442, 10.3748/wjg.v16.i12.1442

Hunter J. The official website of Professor John Hunter – Everything You’ll Ever Need to Know About IBD: Crohn’s Disease (CD). URL: http://crohns.nutricia.co.uk/crohns_disease (accessed 25 October 2013).

Crohn’s in Childhood Research Association (CICRA). What is IBD: Children with Crohn’s Disease. URL: www.cicra.org/what-is-ibd/children-with-crohns-disease (accessed 14 November 2013).

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Ann Intern Med, 151, 264, 10.7326/0003-4819-151-4-200908180-00135

Higgins, 2011, The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials, BMJ, 343, d5928, 10.1136/bmj.d5928

Drummond, 2005, Methods for the Economic Evaluation of Health Care Programmes, 10.1093/oso/9780198529446.001.0001

DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2

Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration:2011 URL: www.cochrane-handbook.org (accessed 1 October 2013).

Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629

Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ (Clinical research ed), 336, 924, 10.1136/bmj.39489.470347.AD

Guyatt, 2011, GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables, J Clin Epidemiol, 64, 383, 10.1016/j.jclinepi.2010.04.026

Guyatt, 2011, GRADE guidelines: 9. Rating up the quality of evidence, J Clin Epidemiol, 64, 1311, 10.1016/j.jclinepi.2011.06.004

Hanai, 2012, Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn’s Disease, Dig Liver Dis, 44, 649, 10.1016/j.dld.2012.03.007

Hirakawa, 1993, Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn’s disease, J Gastroenterol, 28, 379

Takagi, 2006, Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn’s disease: a randomised-controlled trial, Aliment Pharmacol Ther, 24, 1333, 10.1111/j.1365-2036.2006.03120.x

Takagi, 2006, Efficacy of ‘half elemental diet’ as a maintenance therapy for Crohn’s disease: Crohn’s disease half elemental diet study in Sendai (CHESS): a randomised controlled trial, Gastroenterology, 130, A484

Takagi, 2009, Quality of life of patients and medical cost of ‘half elemental diet’ as maintenance therapy for Crohn’s disease: secondary outcomes of a randomised controlled trial, Dig Liver Dis, 41, 390, 10.1016/j.dld.2008.09.007

Verma, 2001, Does adjuvant nutritional support diminish steroid dependency in Crohn disease?, Scand J Gastroenterol, 36, 383, 10.1080/003655201300051199

Verma, 2000, Oral nutritional supplementation is effective in the maintenance of remission in Crohn’s disease, Dig Liver Dis, 32, 769, 10.1016/S1590-8658(00)80353-9

Yamamoto, 2007, Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn’s disease: a prospective study, Inflamm Bowel Dis, 13, 1493, 10.1002/ibd.20238

Yamamoto, 2010, Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohn’s disease, J Gastroenterol, 45, 24, 10.1007/s00535-009-0136-5

Yamamoto, 2013, Enteral nutrition to suppress postoperative Crohn’s disease recurrence: a five-year prospective cohort study, Int J Colorectal Dis, 28, 335, 10.1007/s00384-012-1587-3

Yamamoto, 2013, The long-term efficacy of enteral nutrition for the prevention of postoperative recurrence in Crohn’s disease: a five-year prospective cohort study, J Crohn’s Colitis, 7, S146, 10.1016/S1873-9946(13)60363-3

Yamamoto, 2011, Dietary interventions in patients with inflammatory bowel disease, Pract Gastroenterol, 35, 10, 10.1111/j.1365-2036.2009.04035.x

Wardle, 1992, Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease, Gut, 33, 1644, 10.1136/gut.33.12.1644

Thông tin
Thông tin xuất bản

Health Technology Assessment

Tập 19 Số 26

1-138

Thông tin tác giả